2024 Latest News of Tesiparatide: Approved for Weight Loss Indications! A New Choice for Scientific Weight Loss

With the official approval of tirzepatide for weight loss in 2024 , the global weight loss medical field has ushered in a revolutionary breakthrough. This news is of great significance to the vast number of people suffering from obesity.

I. Tesipatide's weight loss indication approved: A major medical breakthrough in 2024

In early 2024 , the U.S. Food and Drug Administration (FDA) officially approved tesipatide for chronic weight management, a decision based on the outstanding results of multiple clinical trials. In the SURMOUNT series of studies, participants using the highest dose of tesipatide achieved an average weight loss of an astonishing 21.1% , far exceeding the effects of existing weight-loss drugs.

Of particular note is that tesipatide was initially marketed as a treatment for type 2 diabetes ( brand name Mounjaro) , but significant weight loss effects were observed by doctors and patients in clinical use, which prompted the pharmaceutical company to conduct clinical trials specifically for obesity, and it eventually received approval for the weight loss indication.

II. Dual Mechanism: Why is tesipatide so effective?

The key to tesipatide's sensational success in the weight loss field lies in its unique " dual mechanism of action " :

1. GIP/GLP-1 dual receptor agonists : They act on both glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide -1 (GLP-1) receptors, which is the biggest difference between them and single GLP-1 receptor agonists.
2. Triple function :
• Significantly reduces appetite and decreases calorie intake.
• Delaying gastric emptying and increasing satiety
• Improves energy metabolism and promotes fat breakdown
3. Metabolic improvement : In addition to weight loss, it can also improve multiple metabolic indicators such as blood sugar, blood lipids and blood pressure, and has a comprehensive management effect on obesity-related complications.

III. Who is suitable to use tesipatide?

According to FDA approval information, tesipatide is suitable for use in weight loss for the following groups of people:

1. Obese adults : BMI ≥ 30 kg/m²
2. Overweight individuals with complications : BMI ≥ 27 kg/m² and at least one weight-related condition ( such as hypertension, type 2 diabetes, or high cholesterol ).
3. People who have reached a weight plateau : those who have lost some weight through diet and exercise but have entered a plateau phase.

Table: BMI Classification Table for Tesipatide

BMI Classification	Is it applicable?	Additional conditions
<27kg/m²	not applicable	-
27-29.9 kg/m²	Applicable	Must be accompanied by at least one weight-related disease
≥30kg/m²	Applicable	No additional conditions

IV. Guidelines for the Use of Tesipatide: Dosage and Course of Treatment

Tesipatide is administered subcutaneously, typically once a week. Standard treatment regimens include:

1. Dosage escalation :
• Starting dose: 2.5 mg/ week for 4 weeks.
• Maintenance dose: Gradually increase to 5 mg , 7.5 mg , 10 mg , 12.5 mg or 15 mg, depending on tolerability.
2. Optimal treatment course :
• Minimum recommended treatment duration: 12 weeks to assess effectiveness.
• Long-term maintenance: Most patients need to continue using it to maintain the weight loss effect.
3. Combined treatment : It is recommended to combine this with medical nutrition guidance and moderate exercise for better results.

V. Frequently Asked Questions

Q : How long does the weight loss effect of tesipatide last?
A : Clinical trials show that continued use can maintain weight loss for more than 72 weeks. Some patients may experience weight rebound after discontinuing the medication; lifestyle changes are recommended.

Q : What are some common side effects?
A: The most common side effects are gastrointestinal reactions ( nausea, diarrhea, constipation, etc. ) , which are mostly mild to moderate and lessen over time. Serious side effects are rare, but include pancreatitis and gallbladder disease.

Q : What are the advantages compared to other weight loss drugs?
A : Compared to single GLP-1 agonists, tesipatide has a more significant weight loss effect ( averaging about 5-7% more weight loss ) and a more comprehensive improvement in metabolism.

VI. Why choose us?

l  Authentic tesipatide (global cold chain shipping)

l  Hospital prescription

l  Online doctor consultation

l  Pharmacist Medication Instructions

Scientific weight loss leads to better health! Tesipatide offers a new option for obesity treatment, but everyone's situation is different. It is recommended to develop a personalized weight loss plan under the guidance of a professional medical professional. We hope this innovative drug can help more people achieve a healthy weight and embrace a better life.

-------------------------------------------------------------------------------------